Department of Neurosurgery, Johns Hopkins University School of Medicine, 600 N. Wolfe St, Meyer 5-185A, Baltimore, MD 21287, USA.
Department of Neurosurgery, Johns Hopkins University School of Medicine, 600 N. Wolfe St, Meyer 5-185A, Baltimore, MD 21287, USA; Department of Orthopaedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Spine J. 2021 Jan;21(1):20-27. doi: 10.1016/j.spinee.2020.05.540. Epub 2020 May 28.
Current evidence suggests that dual-energy x-ray absorptiometry (DXA) scans, the conventional method defining osteoporosis, is underutilized and, when used, may underestimate patient risk for skeletal fragility. It has recently been suggested that other imaging modalities may better estimate bone quality, such as the magnetic resonance imaging (MRI)-based vertebral bone quality (VBQ) score which also may assess vertebral compression fracture risk in patients with spine metastases.
To evaluate whether VBQ score is predictive of fragility fractures in a population with pre-existing low bone density and at high-risk for fracture.
STUDY DESIGN/SETTING: Retrospective single-center cohort.
Patients followed at a metabolic bone clinic for osteopenia and/or osteoporosis.
Radiographically-documented new-onset fragility fracture.
Patients with a DXA and MRI scans at the time of consultation and ≥2-year follow-up were included. Details were gathered about patient demographics, health history, current medication use, and serological studies of kidney function and bone turnover. For each patient, VBQ score was calculated using T1-weighted lumbar MRI images. Univariable and multivariable analyses were used to identify the independent predictors of a new fragility fracture. To support the construct validity of VBQ, patient VBQ scores were compared to those in a cohort of 45 healthy adults.
Seventy-two (39.1%) study participants suffered fragility fractures, the occurrence of which was associated with higher VBQ score (3.50 vs. 3.01; p<.001), chronic glucocorticoid use (30.6% vs. 15.2%; p=.014), and a history of prior fragility fracture (36.1% vs. 21.4%; p=.030). Mean VBQ score across all patients in the study cohort was significantly higher than the mean VBQ score in the healthy controls (p<.001). In multivariable analysis, new-onset fracture was independently associated with history of prior fracture (OR=6.94; 95% confidence interval [2.48-19.40]; p<.001), higher VBQ score (OR=2.40 per point; [1.30-4.44]; p=.003), higher body mass index (OR=1.09 per kg/m²; [1.01-1.17]; p=.03), and chronic glucocorticoid use (OR=2.89; [1.03-8.17]; p=0.043). Notably, DXA bone mineral density (BMD) was not found to be significantly predictive of new-onset fractures in the multivariable analysis (p=.081).
Here we demonstrate the novel, MRI-derived VBQ score is both an independent predictor of fragility fracture in at-risk patients and a superior predictor of fracture risk than DXA-measured BMD. Given the frequency with which MRIs are obtained by patients undergoing spine surgery consultation, we believe the VBQ score could be a valuable tool for estimating bone quality in order to optimize the management of these patients.
目前的证据表明,双能 X 射线吸收法(DXA)扫描是定义骨质疏松症的常规方法,但该方法的应用不足,而且在应用时可能会低估患者骨骼脆弱的风险。最近有人提出,其他成像方式可能更好地估计骨质量,例如基于磁共振成像(MRI)的椎体骨质量(VBQ)评分,该评分还可以评估脊柱转移瘤患者的椎体压缩性骨折风险。
评估 VBQ 评分是否可预测存在先前低骨密度且骨折风险较高的人群中的脆性骨折。
研究设计/地点:回顾性单中心队列研究。
在代谢性骨科诊所就诊的骨质疏松症和/或骨质疏松症患者。
72 名(39.1%)研究参与者发生了脆性骨折,其发生与较高的 VBQ 评分(3.50 与 3.01;p<.001)、慢性糖皮质激素使用(30.6%与 15.2%;p=.014)和既往脆性骨折史(36.1%与 21.4%;p=.030)相关。研究队列中所有患者的平均 VBQ 评分明显高于健康对照组的平均 VBQ 评分(p<.001)。在多变量分析中,新发骨折与既往骨折史(OR=6.94;95%置信区间 [2.48-19.40];p<.001)、较高的 VBQ 评分(OR=2.40 每分;[1.30-4.44];p=.003)、较高的体重指数(OR=1.09 每千克/平方米;[1.01-1.17];p=.03)和慢性糖皮质激素使用(OR=2.89;[1.03-8.17];p=0.043)独立相关。值得注意的是,DXA 骨密度(BMD)在多变量分析中并未显示出对新发骨折的显著预测作用(p=.081)。
在这里,我们证明了新型 MRI 衍生的 VBQ 评分不仅是高危患者脆性骨折的独立预测因子,而且是 DXA 测量的 BMD 更好的骨折风险预测因子。鉴于脊柱手术咨询患者经常接受 MRI 检查,我们认为 VBQ 评分可能是评估骨质量的有价值工具,以优化这些患者的管理。